Ferrer Germany appoints Olaf Gerber as country manager 

Home 9 Appointment 9 Ferrer Germany appoints Olaf Gerber as country manager 
Appointment
Barcelona, Spain, February 5, 2024 – Ferrer, an international pharmaceutical company, today announces the appointment of Olaf Gerber as its country manager for Germany, effective February 1, 2024.  Mr. Gerber will be based in Herzogenrath and will oversee the implementation of Ferrer’s strategic plan for 2024-2028, to support the company’s development in the German market and to launch innovative product […]

Barcelona, Spain, February 5, 2024 – Ferrer, an international pharmaceutical company, today announces the appointment of Olaf Gerber as its country manager for Germany, effective February 1, 2024. 

Mr. Gerber will be based in Herzogenrath and will oversee the implementation of Ferrer’s strategic plan for 2024-2028, to support the company’s development in the German market and to launch innovative product lines in the country. He succeeds Amina Elsner, who has been appointed head of medical affairs for North-East Europe.

He brings over 30 years of experience in the pharmaceutical industry and has worked in various roles across sales, marketing and strategy at local, regional and global levels. He also has expertise across multiple therapeutic areas, including several benchmark launches, within different market access environments.

Mr. Gerber has spent most of his career at Bayer, in various countries including Germany, Switzerland and the Nordic region. Most recently, he served as managing director at Jenapharm, a German Bayer subsidiary. He is passionate about his team’s personal and professional development, the evolution of the go-to-market model and fostering innovation.

“For me, it has always been a privilege to work in the pharmaceutical industry. In joining Ferrer, with its unique purpose, I am absolutely committed to leveraging the opportunities ahead with the German team and strengthening the company’s ‘for good’ culture,” said Olaf Gerber.


About Ferrer

At Ferrer we make a positive impact on society and meet the highest standards of social and environmental performance, transparency and corporate responsibility, in every territory in which we have a direct presence. That is why in 2022 we became a B Corp® company.

In order to fulfil our purpose, we offer transformative therapeutic solutions, with an increasing focus on pulmonary vascular and interstitial lung diseases and neurological disorders.

Founded in Barcelona in 1959, our products are present in more than a hundred countries. We have a team of over 1,800 people; professionals that we empower and accompany in their learning and wellbeing so that they are proud of working at Ferrer.

We are Ferrer. Ferrer for good.

www.ferrer.com

To download documents, you can right-click on the links above and chose « Save link as… »